Sun, Daphne
Dalin, Simona
Hemann, Michael T.
Lauffenburger, Douglas A.
Zhao, Boyang
Article History
Received: 30 June 2016
Accepted: 11 October 2016
First Online: 7 November 2016
Competing interests
: D.A.L. is a consultant/advisory board member of Merrimack Pharmaceuticals, Genentech, and Complete Genomics. Remaining authors declare no potential conflict of interests.